Key result
Atherosclerotic cardiovascular disease promotes cancer onset and progression through cardiac-secreted factors, altered hematopoiesis, and innate immune changes.
Why the study?
CVD impacts cancer onset and progression, but the underlying mechanisms linking atherosclerotic CVD to cancer promotion remain unclear.
Atherosclerotic cardiovascular disease may promote cancer development through systemic mechanisms, highlighting the potential benefit of targeting inflammation and shared risk factors.
Answers are grounded in this paper and cite their sources.
May support targeting inflammation and risk factors in CVD to improve cancer outcomes; leaves open mechanistic roles of cardiac-secreted factors.
•CVD impacts cancer onset and progression, yet the underlying mechanisms remain unclear.•Cardiac-secreted factors, altered hematopoiesis, and innate immune changes link atherosclerotic CVD to cancer promotion.•Addressing common risk factors, enhancing surveillance, and targeting inflammation in CVD patients may improve cancer outcomes.
No takes yet. Share an insight, caveat, or question.
Dalman et al. (2025) studied this question. Atherosclerotic cardiovascular disease promotes cancer onset and progression through cardiac-secreted factors, altered hematopoiesis, and innate immune changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: